Life Technologies provides products and services to customers conducting scientific research and genetic analysis.
Healthcare equipment company Thermo Fisher Scientific has signed a $13.6 billion deal to acquire Life Technologies Corp., a global biotechnology company servicing the fields of scientific research, genetic analysis and applied sciences.
According to Thermo Fisher Scientific, the transaction "will create an unrivaled leader in serving research, speciality diagnostics and applied markets."
“We are extremely excited about this transaction because it creates the ultimate partner for our customers and significant value for our shareholders,” said Marc N. Casper, president and chief executive officer of Thermo Fisher Scientific. “The acquisition of Life Technologies enhances all three elements of our growth strategy: technological innovation, a unique customer value proposition and expansion in emerging markets.
RELATED: Thermal Fisher Scientific activates global Food Safety Response Center
Life Technologies provides products and services to customers conducting scientific research and genetic analysis, as well as those in applied markets, such as forensics and food safety testing. With 2012 revenues of $3.8 billion, its offering includes a broad range of reagents, consumables, instruments and systems.